Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Diabetes Obes Metab. 2022 Nov 4;25(2):426–434. doi: 10.1111/dom.14885

Figure 1.

Figure 1.

Epicardial and paracardial adipose tissue area in NGT controls and T2DM patients before (Pre-Pio) and after (Post-Pio) pioglitazone treatment. A significant (p = 0.03) decrease in EAT area was noted Post-Pio.